NCT06852105View on ClinicalTrials.gov

Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK

NANot yet recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

May 28, 2026

Study Completion Date

May 31, 2026

Conditions
Dry EyeTear Break-Up Time
Interventions
DRUG

3% Diquafosol Sodium Eye Drops

3% Diquafosol Sodium Eye Drops were instilled into the inferior conjunctival vault of both eyes

DRUG

0.1% hyaluronic acid

0.1% sodium hyaluronate eye drops were instillation into the inferior conjunctival vault of both eyes

All Listed Sponsors
lead

He Eye Hospital

OTHER

NCT06852105 - Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK | Biotech Hunter | Biotech Hunter